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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYThis study investigated human-induced pluripotent stem cell (hiPSC) -derived neurons for their ability to secrete neurotransmitters in an
activity-dependent manner, the fundamental property required for chemical neurotransmission. Cultured hiPSC neurons showed KCl
stimulation of activity-dependent secretion of catecholamines—dopamine (DA), norepinephrine (NE), and epinephrine (Epi)—and
the peptide neurotransmitters dynorphin and enkephlain. hiPSCneurons express the biosynthetic enzymes for catecholamines and neu-
ropeptides. Because altered neurotransmission contributes to schizophrenia (SZ), we compared SZ to control cultures of hiPSC neurons
and found that SZ cases showed elevated levels of secreted DA, NE, and Epi. Consistent with increased catecholamines, the SZ neuronal
cultures showed a higher percentage of tyrosine hydroxylase (TH)-positive neurons, the first enzymatic step for catecholamine biosyn-
thesis. These findings show that hiPSC neurons possess the fundamental property of activity-dependent neurotransmitter secretion and
can be advantageously utilized to examine regulation of neurotransmitter release related to brain disorders.INTRODUCTION
Neurotransmitters are critical for nervous system control of
behaviors and physiological functions (Kandel et al., 2000;
Holz and Fisher, 2012). The challenge in gaining insight
into regulation of neurotransmitter secretion in human
brain disorders has been the lack of human neuronal
models from individual clinical cases. The human-induced
pluripotent stem cell (hiPSC) neuronal approach has the
capability to assess human brain cellular properties and
may potentially be able to address the fundamental prop-
erty of activity-dependent secretion of neurotransmitters
required for chemical neurotransmission.
We therefore asked whether neurons differentiated from
hiPSCs (Brennand et al., 2011; Peitz et al., 2013) possess
the ability to secrete neurotransmitters in an activity-
dependent manner, and whether biosynthetic enzymes
for neurotransmitters are expressed. Further, to determine
whether hiPSC neurons can be utilized to study neuro-
transmitter secretion related to a psychiatric brain disorder,
we tested schizophrenia (SZ) hiPSC-derived neurons to
answer the question of whether alterations in secreted neu-
rotransmitters are recapitulated, including dopamine,
which plays a role in SZ (Seeman, 1987; Coyle and Kono-
pask, 2012; Eyles et al., 2012).
hiPSC neurons displayed activity-dependent, regulated
secretion of catecholamine and peptide neurotransmittersStem Cell(neuropeptides), and expressed the biosynthetic enzymes
for these neurotransmitters. Relative to healthy controls,
hiPSC neuronal cultures derived from SZ patients showed
increases of the catecholamines dopamine (DA), norepi-
nephrine (NE), and epinephrine (Epi). Consistent with
this, SZ-derived hiPSC neuronal populations had a higher
percentage of tyrosine hydroxylase (TH)-positive neurons,
the first enzymatic step for catecholamine biosynthesis,
suggesting a change in the number of catecholaminergic
neurons in SZ hiPSC neuronal cultures. Overall, these find-
ings show that hiPSC neurons possess the fundamental
property of activity-dependent neurotransmitter release,
demonstrating their value as a platform with which to
investigate normal and abnormal neurotransmitter secre-
tion related to brain function.
RESULTS
Activity-Dependent Secretion of Catecholamine
and Peptide Neurotransmitters in hiPSC Neurons
Neurotransmission requires activity-dependent secretion of
neurotransmitters (Kandel et al., 2000), and KCl-stimulated
secretion is widely used as a model of activity-dependent,
regulated secretion of neurotransmitters (Cavallero et al.,
2009; Toneff et al., 2013). We incubated neurons with
highKCl (50mM) in the culturemedia to stimulate depolar-
ization-mediated secretion and measured the release ofReports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Authors 531
Figure 1. Activity-Dependent Secretion of
Catecholamines and Neuropeptides from
hiPSC Neurons
(A–C) Activity-dependent, regulated secre-
tion was stimulated by high KCl in the medium
(50 mM KCl, 30 min). The hiPSC neurons were
derived from biopsies from healthy control
individuals and were subjected to secretion
in the absence or presence of KCl for basal
and stimulated secretion, respectively. The
collected media were assayed for levels of
catecholamines dopamine (DA), norepineph-
rine (NE), and epinephrine (Epi), illustrated
in (A), (B), and (C), respectively (from control
cell lines 94293A, 4506CB, and BJ3E,
respectively).
(D and E) In addition, the peptide neuro-
transmitters (neuropeptides) dynorphin A
(Dyn. A) and (Met)enkephalin (Enk.) in the
secretion media were measured by radioim-
munoassay, illustrated in (D) and (E), res-
pectively (from control cell line 4506CB).
Results are shown as the mean ± SEM, for neurotransmitters secreted under conditions of KCl-stimulated and basal secretion (n = 3 per
experiment. Experiments utilized triplicate wells of cells for each condition; neurotransmitter measurements for each well were conducted
in triplicate assays, and experiments were conducted twice. This experiment was also conducted with independent cell lines from three
controls and 3 SZ patients, shown in Figure S1.
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control hiPSC neurons during stimulation with KCl. KCl
induced the secretion of DA, NE, and Epi at levels that
were two to three times above those of basal secretion (Fig-
ures 1A–1C). The secretion of the neuropeptides dynorphin
A and (Met)enkephalin was also stimulated by KCl (Figures
1D and 1E). These results demonstrate that hiPSC neurons
possess the property of activity-dependent, regulated secre-
tion of neurotransmitters.
Neurotransmitter Biosynthetic Enzymes in
hiPSC Neurons
The presence of the biosynthetic enzymes for catechol-
amines and neuropeptides in hiPSC neurons was assessed
by immunofluorescence confocal microscopy. The cate-
cholamine biosynthetic enzymes DOPA decarboxylase
(DDC), dopamine b-hydroxylase (DBH), and phenyletha-
nolamine N-methyltransferase (PNMT) generate DA, NE,
and Epi, respectively. All of these enzymes were observed
in hiPSC neurons. DDC was distributed throughout the
neurons, consistent with the cytoplasmic location of
DDC (Figure 2Ai). The discrete, punctate pattern of DBH
subcellular distribution is consistent with its known pres-
ence in secretory vesicles for conversion of DA to NE (after
transport of cytoplasmic DA into secretory vesicles, Fig-
ure 2Aii). PNMT was observed throughout hiPSC neurons,
consistent with its known presence in the cytoplasm for532 Stem Cell Reports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Abiosynthesis of Epi, which then is transported to secretory
vesicles for secretion (Figure 2Aiii).
Neuropeptide transmitters are synthesized as proneuro-
peptide precursor proteins that undergo proteolytic pro-
cessing by two main protease pathways composed of the
cysteine proteases cathepsin L and cathepsin V, and the
subtilisin-like proteases prohormone convertases 1/3 and
2 (PC1/3 and PC2) (Hook et al., 2008; Seidah and Prat,
2012; Funkelstein et al., 2012). Cathepsins L and V were
both observed in hiPSC neurons by immunofluorescence
microscopy (Figure 2Bi and ii) and were present in a punc-
tate pattern of subcellular localization consistent with their
known localization to secretory vesicles for neuropeptide
production. PC1/3 and PC2 immunofluorescence was
also observed in a discrete pattern of subcellular distribu-
tion (Figure 2Biii and iv). These data indicate that hiPSC
neurons possess neurotransmitter-synthesizing enzymes
for catecholamines and neuropeptides.
SZ hiPSC Neurons Display Increased Secretion of
DA, NE, and Epi Released in an Activity-Dependent
Manner
We compared catecholamines secreted by SZ hiPSC neu-
rons to those derived from healthy controls. Secretion of
DA, NE, and Epi under basal conditions was greater in SZ
hiPSC neurons relative to controls (Figures 3A–3C). Impor-
tantly, SZ hiPSC neurons showed increased amounts ofuthors
Figure 2. Biosynthetic Enzymes of Cate-
cholamines and Neuropeptides Expressed
in hiPSC Neurons
(A) Catecholamine biosynthetic enzymes
in hiPSC neurons. Immunofluorescence
confocal microscopy demonstrated the
presence of the catecholamine biosyn-
thetic enzymes DOPA decarboxylase (DDC),
dopamine b-hydroxylase (DBH), and phe-
nylethanolamine N-methyltransferase
(PNMT) as shown in i, ii, and iii, respec-
tively. These enzymes participate in the
synthesis of DA, NE, and Epi, respectively.
Enzyme immunofluorescence (green) was
visualized with secondary anti-rabbit Alexa
Fluor 488 (from Invitrogen). Nuclei were
stained with DAPI blue. Controls conducted
without primary antisera (directed to the
enzymes) resulted in lack of immunofluo-
rescence, demonstrating specific detection
of the enzymes.
(B) Neuropeptide biosynthetic enzymes in hiPSC neurons. The presence of the proneuropeptide processing enzymes was assessed by
immunofluorescence confocal microscopy for the cysteine proteases cathepsin L and cathepsin V (human) (Hook et al., 2008; Funkelstein
et al., 2012) (i and ii, respectively) and the subtilisin-like proteases of prohormone convertases 1 and 2 (PC1/3 and PC2) (iii and iv,
respectively) (Seidah and Prat, 2012). Enzyme immunofluorescence was visualized with secondary anti-rabbit Alexa Fluor 488 (green
fluorescence, from Invitrogen). Nuclei were stained with DAPI blue. The discrete localization of these neuropeptide biosynthetic enzymes
is consistent with their localization in secretory vesicles, the primary intracellular site of neuropeptide production (Hook et al., 2008).
Experiments in (A) and (B) were conducted twice with two or three different control neuronal hiPSC cell lines, with each experiment
conducted with duplicate or triplicate cell samples.
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tive to controls (Figures 3A–3C). The ratios of these cate-
cholamines secreted in an activity-dependent manner,
stimulated by KCl, above baseline untreated levels was
similar in SZ relative to control hiPSC neurons (Table S1
available online). These neurotransmitter secretion data
were obtained as averages from hiPSC neurons derived
from three SZ patients and three healthy controls (average
values shown in Table S1). Values for individual SZ and
control cell lines are shown in Table S2 and graphed in
Figure S1.
With respect to secretion of neuropeptides, the SZ hiPSC
neurons showed a 25% decrease in KCl-stimulated dynor-
phin A secretion (Figure 3D) compared to controls, but
the decrease was not significant. There was no change in
the amounts of (Met)enkephalin secreted from SZ and con-
trol hiPSC neurons (Figure 3E). Table S1 shows the average
secretion values of cell lines from the three SZ cases and
three control cases. Values for individual hiPSC cell lines
are shown in Table S2 with graphs shown in Figure S1.
SZ hiPSC Cultures Show Increased Percentage of
TH-Positive Neurons
Elevated secretion of all three catecholamines tested (DA,
NE, and Epi) in SZ hiPSC neurons suggested that tyrosineStem Cellhydroxylase (TH), the first and common enzymatic step
of the catecholamine biosynthetic pathway, might be
affected. Cell counts of TH-positive cells revealed that the
percentage of TH-positive bIII-TUBULIN-positive hiPSC
neurons was significantly increased in SZ relative to
healthy controls (Figure 4). Notably, this difference was
only observed when calculating the percentage of TH-pos-
itive cells relative to bIII-TUBULIN-positive neurons, and
not when relative to total DAPI-positive nuclei (data not
shown). However, analyses of DDC, DBH, and PNMT by
gene expression microarray (Brennand et al., 2011) and
western blots showed no change in levels of these biosyn-
thetic enzymes for DA, DBH, and Epi, respectively (data
not shown). This result is consistent with elevations in
secreted amounts of all three catecholamines (Figure 3).DISCUSSION
Activity-dependent regulated neurotransmitter secretion is
a fundamental requirement for neuronal communication.
This study shows that hiPSC neurons display activity-
dependent, regulated secretion of the catecholamines DA,
NE, and Epi, as well as the peptide neurotransmitters dy-
norphin A and (Met)enkephalin, when stimulated by KClReports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Authors 533
Figure 3. SZ hiPSC Neurons Display Increases in Dopamine, Norepinephrine, and Epinephrine Secreted in an Activity-Dependent
Manner, Compared to Control hiPSC Neurons
Schizophrenia (SZ) and control hiPSC neurons were compared with respect to levels of neurotransmitters secreted in an activity-dependent
manner, stimulated by KCl. The hiPSC neurons were derived from three SZ patients and from three healthy controls (as described in
Experimental Procedures). Experimental conditions in each hiPSC neuronal cell line were conducted in triplicate. Neurotransmitter levels
in basal and KCl-stimulated secretion media were measured for the catecholamines DA, NE, and Epi, and for the neuropeptides dynorphin A
(Dyn. A) and (Met)enkephalin (Enk.). Results are shown as the mean ± SEM of three different control and three different SZ hiPSC neuronal
cell lines; each cell line was studied in triplicate samples of neuronal cells. Average values of the three different cell lines for control, and
SZ groups are shown in Table S1. Neurotransmitter secretion data for each individual control and SZ hiPSC neuronal cell line are shown in
Figure S1 and Table S2, and experiments were conducted twice.
Data showed significant differences in levels of catecholamines secreted from SZ hiPSC neurons compared to control hiPSC neurons upon
KCl stimulation (*p < 0.05, Student’s t test). In addition, basal secretion of catecholamines was significantly increased in SZ compared to
control neurons (+p < 0.05, Student’s t test).
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transmitters is supported by the presence of the catechol-
amine biosynthetic enzymes DDC, DBH, and PNMT, as
well as TH, the first enzymatic step for biosynthesis of cat-
echolamines. hiPSC neurons also express the neuropeptide
biosynthetic enzymes composed of cysteine proteases,
cathepsin L and cathepsin V, and the subtilisin-like prohor-
mone convertases 1 and 2 (PC1/3 and PC2). Thus, hiPSC
neurons produce and secrete neurotransmitter molecules,
indicating that they are a relevant platform for the study
of aberrant neurotransmitter systems in human disease.
hiPSC neurons derived from three patients with SZ,
compared to controls, showed elevated secretion of DA,
NE, and Epi. The increase in secretion of all three catechol-
amines suggests an increase in TH, the first enzymatic step
common to all catecholamine biosynthesis. Consistent
with the increase in catecholamine secretion, we detected534 Stem Cell Reports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Aan increased percentage of TH-positive neurons in hiPSC
neurons derived from these cases of SZ patients. SZ hiPSC
neurons (compared to controls), thus, appear to have
differentiated into, and/or preferentially survived as,
neuronal populations with a larger portion of TH-positive
neurons. These case studies of several SZ patients provide
insight into the hypothesis that catecholamine neuro-
transmitters may be regulated in SZ.
It is important to clarify that increased catecholamine
release does not necessarily indicate increased production
in SZ hiPSC neurons but may instead imply a difference in
the overall activity of one or more neuronal subtypes (Yu
et al., 2014) and/or a change in the composition of
neuronal populations (Robicsek et al., 2013) throughout
the differentiation of these heterogeneous SZ hiPSC
neuronal cultures. Indeed, an increased percentage of
TH-positive neurons was observed in the SZ hiPSC neuronsuthors
Figure 4. Tyrosine Hydroxylase Neurons in SZ hiPSC Neuronal Cultures
SZ hiPSC neurons displayed an increased percentage of TH-positive neurons, illustrated by anti-TH immunofluorescence microscopy (A)
with quantitation (B).
(A) TH immunofluorescence (red) was compared to that of the neuronal marker TUJ-1 (green), providing an indication of the percentage of
TH-positive neurons (colocalized yellow immunofluorescence).
(B) The percentage of TH-positive neurons in SZ hiPSC neuronal cultures was significantly increased compared to controls (mean ± SEM,
with *statistical significance of p < 0.05, Student’s t test, n = 3).
See also Figure S2. Results were compiled from three different control and three different SZ neuronal cell lines (each derived from an
individual patient), conducted in three experiments, with each experiment having three cellular replicates.
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catecholamines detected. A number of possible expla-
nations might account for the increased number of
TH-positive neurons observed, including, but not limited
to, different rates of TH specification, maturation, or sur-
vival relative to other neurons in the culture. Given that
our previously reported microarray comparisons of SZ
and control hiPSC neural progenitor cells (NPCs) (Bren-
nand et al., 2014) and neurons (Brennand et al., 2011)
failed to detect increased patterning of DA and catechol-
amine fate, we posit that the differences observed more
likely reflect differential survival of TH neurons rather
than increased specification. Because changes in TH stain-
ing were not reflected in gene expression differences, this
increase might instead indicate graded levels of protein,
changing protein stability, and/or changes in protein
translation. It is also possible that aberrant regulation of re-
uptake and metabolism of catecholamines in SZ hiPSC
neurons may occur. We further speculate that the
increased oxidative stress that we (Brennand et al., 2014)
and others (Paulsen et al., 2012; Robicsek et al., 2013)
have reported in SZ hiPSC neurons may be contributing
to our observed results, and note that increased TH stain-
ing is generally reflected in neurons derived from higher
passage NPCs, which might have been exposed to
increasing amounts of stress with increased time in cul-
ture. Finally, because the observed increase in TH-positive
neurons was heavily skewed by results in two of three SZ
patients, we predict that in future studies of larger cohorts,Stem CellhiPSC neurons derived from some but not all SZ patients
may show this effect. Thus, the variability between
patient-derived neurons in vitro may reflect real variance
between SZ patients and could underlie, in part, the dif-
ferences in drug responsiveness among patients. The
molecular and cellular mechanisms contributing to these
differences remain to be elucidated.
The increase in the portion of TH-positive (relative to
bIII-TUBULIN-positive) neurons in SZ hiPSC neurons is
consistent with the upregulation of neuroregulin in SZ
(Kato et al., 2011), which is thought to upregulate the
expression of TH, resulting in increased DA and a hyperdo-
paminergic state (Kato et al., 2011). Alternately, it may be
consistent with increased oxidative stress in SZ brain tissue
causing preferential loss of non-catecholamine-producing
neurons (Behrens et al., 2007). Though a recent postmor-
tem study of SZ patients assessed TH protein levels in the
substantia nigra/ventral tegmental brain area, great vari-
ability was observed among SZ brain samples compared
to controls (Perez-Costas et al., 2012); another study found
decreased TH-immunoreactive axons, but it is not known
whether the data indicated fewer axons from individual
neurons or fewer TH neurons (Akil et al., 2000). Nonethe-
less, these findings, when combined with our results, point
to the importance of TH levels in SZ.
Increased DA secretion from SZ hiPSC neurons is consis-
tent with the ability of current antipsychotics, functioning
as D2 DA receptor antagonists, to ameliorate the positive
symptoms of SZ (Seeman, 1987; Coyle and Konopask,Reports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Authors 535
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tipsychotics lack efficacy for improving the cognitive
dysfunction of SZ (Heinrichs and Zakzanis, 1998; Young
et al., 2012; Coyle and Konopask, 2012), it is possible
that neurotransmitters other than DA contribute to SZ
such as those identified in hiPSC neuronal models. Other
neurotransmitter systems involved in SZ may include
glutamate (Snyder and Gao, 2013; Menniti et al., 2013), se-
rotonin (Meltzer et al., 2012), and GABA (Volk and Lewis,
2013). It will be advantageous in future studies to charac-
terize the activity-dependent release of these other neuro-
transmitter systems in SZ hiPSC neurons.
Great progress has been achieved in recent years in devel-
opment of hiPSC neuronal systems to model human brain
diseases (Kiskinis and Eggan, 2010; Brennand et al., 2011;
Young and Goldstein, 2012; Peitz et al., 2013). The ability
to investigate the critical property of activity-dependent
neurotransmitter release from hiPSC neurons derived
frompatients afflicted withmental disorders and neurolog-
ical diseases can provide knowledge of chemical neuro-
transmitter mechanisms in brain disorders.EXPERIMENTAL PROCEDURES
hiPSC Neurons Derived from Control and SZ Patients
Control and SZ hiPSC neurons were derived from patient samples
as we have described (Brennand et al., 2011). Patient samples
were obtained from the Coriell collection. SZ patient GM01792
was a male, 26 years of age, Jewish Caucasian, who displayed agita-
tion, delusions, and fear of assassination. Patient GM02038 was a
male, 22 years old, who was diagnosed at 6 years of age and
committed suicide at 22. Patient GM2497 was a male, 27 years
old, Jewish Caucasian, who was diagnosed at age 15 years and
showed symptoms including paralogical thinking, affective shield-
ing, and suspiciousness. Healthy control hiPSC neurons were
derived from AG09429 (female, 25 years old), GM04506 (female,
22 years of age), and BJ (male, newborn, from fibroblasts obtained
from ATCC).
Preparation of hiPSC neurons was conducted as we have
described (Brennand et al., 2011). Briefly, SZ and control fibroblasts
were reprogrammed with tetracycline-inducible lentiviruses ex-
pressing the transcription factors OCT4, SOX2, KLF4, mCYC, and
LIN28. The hiPSCs were differentiated to replicating neural pro-
genitor cells and then to mature neurons via BDNF, GDNF, dibu-
tyryl-cAMP, and ascorbic acid. Differentiation into neurons has
been characterized with neuron-specific markers of bIII-tubulin,
MAP2AB, PSD95, vGLUT, and GAD (Brennand et al., 2011).
KCl-Stimulated and Basal Neurotransmitter Secretion
from hiPSC Neurons in Culture
Cultured hiPSC neuronal cell lines (3 months age) from the SZ and
control patients were subjected to treatment with high KCl in the
medium (50 mM, 30 min), which depolarizes neurons to result in
activity-dependent stimulation of secretion (Toneff et al., 2013).
KCl depolarization represents a model of activity-dependent536 Stem Cell Reports j Vol. 3 j 531–538 j October 14, 2014 j ª2014 The Aneurotransmitter secretion from the regulated secretory pathway
of cultured neurons. Basal secretion without KCl was conducted
in parallel, which represents constitutive secretion. Secretion
media were collected for measurements of the catecholamines
DA, NE, and Epi, as well as the peptide neurotransmitters (Met)
enkephalin and dynorphin A.
Measurement of Secreted Catecholamines and Peptide
Neurotransmitters
The catecholamines DA, NE, and Epi were assayed in the media as
described previously (Kennedy and Ziegler, 1990). The peptide
neurotransmitters (Met)enkephalin and NPY were measured by
radioimmunoassays (Phoenix Pharmaceuticals). Assays were con-
ducted from triplicate cell-culture wells for basal and KCl-stimu-
lated conditions.
Immunofluorescence Microscopy of Neurotransmitter
Biosynthetic Enzymes
Immunofluorescence histochemistry of neurotransmitter biosyn-
thetic enzymes was assessed by deconvolution microscopy, as we
have described (Funkelstein et al., 2012). Briefly, hiPSC neurons
were fixed in 4% paraformaldehyde (PFA), permeabilized with
0.1% Triton X-100 (5–10 min), blocked in 3% BSA in PBS
(30min), and incubatedwithprimary antibodies directed toneuro-
transmitter biosynthetic enzymes. Antisera to DDC, DBH, and
PNMT (rabbit antisera from Millipore, AB 1569, AB1585, and
AB110, respectively, at 1:75, 1:100, and 1:100 dilution) were incu-
bated with fixed cells for 2 hr at room temperature in 3% BSA in
PBS, followed by incubation with secondary antibody consisting
of goat anti-rabbit Alexa Fluor 488 for green immunofluorescence
(1:300, Molecular Probes/Life Technologies) for 45 min at room
temperature in3%BSA inPBS.DAPI stainingofnucleiwas also con-
ducted. Immunofluorescence was examined with the Delta Vision
Spectris Image Deconvolution System on anOlympus IX70micro-
scopeusing SoftworxExplorer software (AppliedPrecision). As con-
trol, incubation with only secondary antibodies was performed,
which resulted in a lackof immunofluorescence, indicating specific
immunofluorescence observed with the primary antisera.
For TH immunfluorescence staining, fixed neurons were blocked
in 3% normal goat serum (in TBS), incubated with anti-TH (1:200,
rabbit, from Pel-Freeze Biologicals) or anti-TUJ-1 (1:500, mouse,
from Covance) at 4C overnight, washed, incubated with second-
ary antibody (1:200, anti-rabbit-cy3 or anti-mouse-FITC, respec-
tively) 45 min at room temperature followed by washing, and
observed by LSM780 confocal microscopy (Zeiss).
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